Ignite Creation Date:
2025-12-25 @ 12:11 AM
Ignite Modification Date:
2026-01-01 @ 12:29 PM
Study NCT ID:
NCT00315458
Status:
TERMINATED
Last Update Posted:
2012-09-03
First Post:
2006-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
Sponsor:
Purdue Pharma LP
Organization: